William Valle's most recent trade in TriSalus Life Sciences Inc was a trade of 35,000 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 29, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
TriSalus Life Sciences Inc | William Valle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 35,000 | 35,000 | - | - | Director Stock Option (right to buy) | |
TriSalus Life Sciences Inc | William Valle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 6,250 | 6,250 | - | - | Director Stock Option (right to buy) | |
American Oncology Network ... | William Valle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2024 | 14,981 | 14,981 | - | 0 | Class A Common Stock |